1. Home
  2. VLN vs KRRO Comparison

VLN vs KRRO Comparison

Compare VLN & KRRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Valens Semiconductor Ltd.

VLN

Valens Semiconductor Ltd.

N/A

Current Price

$1.72

Market Cap

206.8M

Sector

Technology

ML Signal

N/A

Logo Korro Bio Inc.

KRRO

Korro Bio Inc.

N/A

Current Price

$12.19

Market Cap

187.9M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
VLN
KRRO
Founded
2006
2014
Country
Israel
United States
Employees
N/A
N/A
Industry
Semiconductors
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
206.8M
187.9M
IPO Year
2021
2019

Fundamental Metrics

Financial Performance
Metric
VLN
KRRO
Price
$1.72
$12.19
Analyst Decision
Strong Buy
Buy
Analyst Count
1
12
Target Price
$3.00
$34.80
AVG Volume (30 Days)
784.5K
71.4K
Earning Date
05-13-2026
05-13-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$6,392,000.00
Revenue This Year
$8.37
N/A
Revenue Next Year
$16.99
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
181.46
52 Week Low
$1.10
$5.20
52 Week High
$3.71
$55.89

Technical Indicators

Market Signals
Indicator
VLN
KRRO
Relative Strength Index (RSI) 41.78 37.94
Support Level $1.40 $9.76
Resistance Level $1.76 $14.42
Average True Range (ATR) 0.09 0.77
MACD -0.01 -0.21
Stochastic Oscillator 7.14 6.93

Price Performance

Historical Comparison
VLN
KRRO

About VLN Valens Semiconductor Ltd.

Valens Semiconductor Ltd is a provider of semiconductor products, pushing the boundaries of connectivity by enabling long-reach, high-speed video, and data transmission for the audio-video and automotive industries. It operates in two segments: Cross Industry Business, which includes solutions for the non-automotive verticals, including audio-video, industrial, machine vision and medical markets, that deliver superior, plug-and-play convergence and distribution of different interfaces, through a single long-distance category cable; and Automotive segment products enable safe and resilient high-speed in-vehicle connectivity for car architectures, realizing the vision of connected and autonomous cars. The company's geographical revenue is derived from Hungary.

About KRRO Korro Bio Inc.

Korro Bio Inc is a biopharmaceutical company with a mission to discover, develop, and commercialize a new class of genetic medicines based on editing RNA, enabling the treatment of both rare and highly prevalent diseases. It is generating a portfolio of differentiated programs that are designed to harness the body's natural RNA editing process to effect a precise yet transient single base edit. By editing RNA instead of DNA, Korro Bio is expanding the reach of genetic medicines by delivering additional precision and tunability. The company operates and manages its business as one reportable segment and one operating segment, which is the business of discovering, developing and commercializing therapies derived from or incorporating its RNA-editing technology.

Share on Social Networks: